Large-Cell Lung Carcinoma Latest Advances

Journal: Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia

Published: September 22, 2022

Factors for incidence risk and prognosis of synchronous brain metastases in pulmonary large cell carcinoma patients: a population-based study.

Journal: BMC pulmonary medicine

Published: September 05, 2022

Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy.

Journal: Journal of clinical medicine

Published: January 25, 2022

Filters

ASO Visual Abstract: The Prognostic Significance of SMARCA4 Deficiency in Early-Stage Pulmonary Large Cell Carcinoma.

ASO Visual Abstract: The Prognostic Significance of SMARCA4 Deficiency in Early-Stage Pulmonary Large Cell Carcinoma.

ASO Author Reflections: SMARCA4 Deficiency as a Potential Biomarker for Adjuvant Therapy in Pulmonary Large Cell Carcinoma.

ASO Author Reflections: SMARCA4 Deficiency as a Potential Biomarker for Adjuvant Therapy in Pulmonary Large Cell Carcinoma.

The Prognostic Significance of SMARCA4 Deficiency in Early-Stage Pulmonary Large Cell Carcinoma.

The Prognostic Significance of SMARCA4 Deficiency in Early-Stage Pulmonary Large Cell Carcinoma.

Efficacy of combined surgery and pembrolizumab for the treatment of pulmonary large cell carcinoma: a case report.

Efficacy of combined surgery and pembrolizumab for the treatment of pulmonary large cell carcinoma: a case report.

Large cell carcinoma of the lung: LDCT features and survival in screen-detected cases.

Large cell carcinoma of the lung: LDCT features and survival in screen-detected cases.

Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.

Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.

Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer.

Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer.

Spontaneous Haemothorax and Diffuse Pleural Thickening as Unusual Presentations of Undifferentiated Large Cell Carcinoma of the Lung.

Spontaneous Haemothorax and Diffuse Pleural Thickening as Unusual Presentations of Undifferentiated Large Cell Carcinoma of the Lung.

Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.

Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.

Large cell carcinoma of the lung with null immunophenotype: Case report & brief review

Large cell carcinoma of the lung with null immunophenotype: Case report & brief review

Factors for incidence risk and prognosis of synchronous brain metastases in pulmonary large cell carcinoma patients: a population-based study.

Factors for incidence risk and prognosis of synchronous brain metastases in pulmonary large cell carcinoma patients: a population-based study.

Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy.

Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy.